ArticleThe Journal of pathology2020

Phospholipase D1 inhibition sensitizes glioblastoma to temozolomide and suppresses its tumorigenicity.

Dong Woo Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.